The amount of the injection has not been finalized, as the number of claims affecting CTBC Insurance’s financial strength would change as the government changes its disease prevention measures, such as the isolation rules, CTBC Financial spokeswoman Chiu Ya-ling (邱雅玲) said. The cash injection would not reduce Taiwan Life’s capital adequacy too much, Chiu said. Taiwan Life Insurance Co employees pose outside a company office in Taipei in an undated photograph. Photo courtesy of Taiwan Life Insurance CoTaiwan Life’s risk-based capital (RBC) ratio stands at 335 percent and is expected to remain above 300 percent even after injecting capital into CTBC Insurance, she said. Having sold 400,000 COVID-19 insurance policies, CTBC Insurance said that it has assigned more staff to deal with claims as domestic COVID-19 infections climb.
